Tirzepatide Peptide For Sale

Tirzepatide is a synthetic peptide that acts as a dual GIP and GLP-1 receptor agonist. It has been studied for its potential effects on glucose metabolism, insulin secretion, and appetite regulation. Research suggests that it may support glycemic control and weight management through its unique dual action on GIP and GLP-1 pathways.

Tirzepatide For Sale

Source: PubChem

• CAS Number: 2023788-19-2
• Molecular Weight: ~4813.51 g/mol
• Sequence: H-His-Aib-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Lys-Ile-Asp-Glu-Gln-Ala-Glu-Glu-Lys-Asp-Leu-Glu-Ser-Leu-Gln-Glu-Glu-Arg-Leu-Gln-Gly-Gln-Leu-Gln-Glu-Glu-Leu-Glu-Gly-Glu-Leu-Glu-Ser-Leu-Lys-Lys-Lys-Lys-Lys-Lys-Lys-Lys-Lys-Lys-Lys-Lys-Lys-Lys-OH
• Formula: C₂₂₅H₃₄₈N₄₈O₆₈

Product Overview

Tirzepatide is a synthetic peptide that functions as a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist. It has been studied extensively for its role in regulating glucose metabolism, enhancing insulin secretion, and reducing appetite. Research suggests that it may influence weight management, glycemic control, and metabolic health by modulating both GIP and GLP-1 pathways.

Key Details

• Physical Form: Lyophilized powder
• Solubility: Soluble in water
• Purity: ≥98% (by HPLC)
• Storage: Store in a dry, cool place, away from direct sunlight and moisture.

Disclaimer

All products sold on Elite Miami Peptides are intended for laboratory research purposes only. They are not intended for human consumption, therapeutic use, or clinical treatment. Tirzepatide is not classified as a prescription drug, over-the-counter medication, or dietary supplement and does not make any health claims or guarantees. Elite Miami Peptides does not sell or endorse products intended to treat or cure any diseases.